CPX-351
1107011830
Phase 1 small_molecule active
Quick answer
CPX-351 for Myelodysplastic Syndromes is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Myelodysplastic Syndromes
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active